Gentamicin

Table of contents

  • Brand Names
  • Drug Combinations
  • Chemistry
  • Pharmacologic Category
  • Mechanism of Action
  • Therapeutic Use
  • Pregnancy and Lactation Implications
  • Contraindications
  • Warnings and Precautions
  • Adverse Reactions
  • Toxicological Effects
  • Genes that may be involved
  • Drug Interactions
  • Dosage
  • Pharmacokinetics and Pharmacodynamics
  • Special Considerations

Brand Names

Europe

Austria: Gentamicin, Gentax, Refobacin; Belgium: Geomycine; Bulgaria: Gentamicin; Cyprus: Gentamed; Czech Republic: Garamycin, Gentamicin; Denmark: Garamycin, Gentacoll, Gentamicin; Estonia: Gentamicin; Finland: Gensumycin, Gentacoll; France: Gentalline, Gentamicine; Germany: Gencin, Gent-Ophtal, Genta, Gentabolus, Gentacin, Gentafromm, Gentamicin, Gentamycin, Gentamytrex, Palasept, Refobacin, Septopal, Soligental, Sulmycin, Terramycin N; Greece: Anfomilan, Centaurin, Chrispacin, Cortolexan, Dabroson, Defarlicine, Diakarmon, Epabe, Fripeintil, Garacol, Garamycin, Garaver, Garbilocin, Gentagen, Gentamedin, Gentamicin, Gentamycin, Isopto Gent, Novoxin, Octoret, Septotal, Septospes, Stovolid, Tefoval, Triclina, Vactiriostam, Velminol, Yedoc; Hungary: Gentamicin; Ireland: Cidomycin, Genoptic, Gentamicin, Genticin; Italy: Ciclozinil, Eutopic, Gentacream, Gentalyn, Gentamen, Gentamicina, Genticol, Gentomil, Nemalin, Ribomicin, Tacigen; Latvia: Gentacip, Gentamicin; Lithuania: Gentamicin; Luxembourg: Duracoll, Gentamicin, Gentamytrex, Geomycine, Ophtagram, Palacos, Refobacin, Septopal; Malta: Garamycin, Gentamed, Gentamicin, Genticin; Netherlands: Garacol, Gentamicine, Gentamicinesulfaat, Gentamycine, Septopal; Poland: Garamycin, Gentamicin, Gentamycin, Gentamytrex; Portugal: Cronocol, Garalone, Genta-Gobens, Gentalin, Gentamicina, Gentocil, Ophtagram, Septopal; Romania: Gentamicin, Gentamicine, Genticol, Lyramycin; Slovakia: Garamycin, Gentamicin; Spain: Genta-Gobens, Gentamicina; Sweden: Garamycin, Gensumycin, Septopal; UK: Cidomycin, Gentamicin, Genticin.

North America

Canada: Diogent, Garamycin, Gentak, Gentamicin, Septopal; USA: Genoptic, Gentak, Gentamicin.

Latin America

Argentina: Gentaderm, Gentamicin, Gentamicina, Gentamina, Gentapharma, Gentaren, Glevomicina, Plurisemina, Provisual, Rupegen; Brazil: Emisgenta, Garacin, Garamicina, Garamin, Gentagran, Gentamicil, Gentamicin, Gentamicina, Gentamil, Gentaron, Septopal, Vitamicin; Mexico: Beramicina, Fustermicina, Garakacin, Garamicina, Geclicin, Genemicin, Genkova, Genrex, Genser, Genta Grin, Gentamicina, Genta-Micron, Gentamil, Gentapat, Gentazaf Z, Gentazol, Gentialoquin, Geracin, G-I, Ikatin, Lifegram, Quilagen, Servigenta, Tamicin-G, Tamigen, Tondex, Yectamicina.

Asia

Japan: Eltacin, Gentacin, Gentalol, Gentamicin, Gernart, Luinesin, Riftamycin.

Drug combinations

Gentamicin and Acexamate

Gentamicin and Betamethasone

Gentamicin and Collagen

Gentamicin and Cyproheptadine

Gentamicin and Dexamethasone

Gentamicin and Diclofenac

Gentamicin and Diflorasone

Gentamicin and Fluorometholone

Gentamicin and Indomethacin

Gentamicin and Prednisolone

Gentamicin and Zirconium Dioxide

Gentamicin, Benzocaine, and Sulfadiazine

Gentamicin, Betamethasone, and Clioquinol

Gentamicin, Betamethasone, and Clotrimazole

Gentamicin, Betamethasone, and Metamizole

Gentamicin, Deoxyribonuclease, and Fibrinolysin

Gentamicin, Dexamethasone, and Tetrahydrozoline

Gentamicin, Dexamethasone, and Tetrizoline

Gentamicin, Diflorasone, and Econazole

Gentamicin, Hydrocortisone, and Ketoconazole

Gentamicin, Hydrocortisone, and Miconazole

Gentamicin, Phenazone and Procaine

Gentamicin, Betamethasone, Iodochlorohydroxyquin, and Tolnaftate

Gentamicin, Betamethasone, Nystatin, and Tolnaftate

Gentamicin, Dexamethasone, Hydrocortisone, and Ketoconazole

Gentamicin, Halibut Oil, Phenazone, and Procaine

Gentamicin, Diflorasone, Econazole, Griseofulvin, Hydrocortisone, Neomycin, and Salicylic Acid

Chemistry

Gentamicin Sulfate: Produced by Micromonospora purpurea sp., it is a complex antibiotic substance with three components, sulfates of gentamicin C~1~, gentamicin C~2~, and gentamicin C~1A~ (O-3-Deoxy-4-C-methyl-3-(methylamino)-β-L-arabinopyranosyl-(1→6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-α-D-erythro-hexopyranosyl-(1→4)]-2-deoxy-D-streptamine). CAS-1405-41-0; CAS-1403-66-3 (gentamicin)(1963).

Pharmacologic Category

Antibacterials; Aminoglycosides. EENT Preparations; Antibacterials. Skin and Mucous Membrane Agents; Antibacterials. Ophthalmic Antibiotic. Topical Antibiotic. (ATC-Code: D06AX07; J01GB03; S01AA11; S02AA14; S03AA06).

Mechanism of action

Interferes with bacterial protein synthesis by binding to 30S and 50S ribosomal subunits resulting in defective bacterial cell membrane.

Therapeutic use

Treatment of susceptible bacterial infections, normally Gram-negative organisms including Pseudomonas, Proteus, Serratia, and Gram-positive Staphylococcus. Treatment of bone infections, respiratory tract infections, skin and soft tissue infections, as well as abdominal and urinary tract infections, endocarditis, and septicemia. Used topically to treat superficial skin infections or ophthalmic infections caused by susceptible bacteria.

Pregnancy and lactiation implications

Gentamicin crosses placenta. Adequate, well-controlled studies not conducted in pregnant women and it is not known whether gentamicin can cause fetal harm. Enters breast milk (small amounts); use caution.

Unlabeled use

Contraindications

Hypersensitivity to gentamicin or other aminoglycosides.

Warnings and precautions

May cause nephrotoxicity (risk factors include pre-existing renal impairment, concomitant nephrotoxic medications, advanced age and dehydration). May cause neuromuscular blockade and respiratory paralysis (especially when given soon after anesthesia or muscle relaxants). May cause neurotoxicity (risk factors include pre-existing renal impairment, concomitant neuro-/nephrotoxic medications, advanced age and dehydration), or ototoxicity. Prolonged use may result in fungal or bacterial superinfection, including C. difficile-associated diarrhea and pseudomembranous colitis. Use with caution in hearing impairment (pre-existing vertigo, tinnitus, or hearing loss). Use with caution in hypocalcemia. Use with caution in neuromuscular disorders, including myasthenia gravis. Use with caution in pre-existing renal insufficiency. Long-term use should be avoided (toxic hazards associated with extended administration).

Information

Legal

Legal Notice
Privacy Policy
Cookie Policy

Contact

Phone: +34-981-780505
Email: genomicmedicine@wagem.org
Location: Sta Marta de, C. P. Babío, S/N, 15165 Bergondo, A Coruña

Copyright © 2023 WAGEM

Add to cart